Jos Jonkers

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Jos Jonkers

Feb 4, 2025, 16:11 | Career

Jos Jonkers - Candidate for the Nominating Committee of AACR

The voting for the 2025 AACR Annual Election is now open, where members will vote…

Jan 21, 2025, 14:07 | Career

2025 AACR Annual Election: Meet the Candidates

The voting for the 2025 AACR Annual Election is now open, where members will vote…

May 27, 2024, 04:00 | Blog

Diego Dibitetto: H2AX downregulation is a new mechanism of chemotherapy resistance in BRCA-deficient tumors

Diego Dibitetto, Postdoc fellow at the University of Bern, shared a post on LinkedIn: "Our new…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023